A examine released in JAMA Network Open up emphasizes the discrepancy amongst what it expenditures to generate copyright plus the retail selling prices patients face. Regardless of the minimal creation charges, Novo Nordisk hasn't publicly disclosed distinct figures for copyright or its othe